Stock screenerAll disclosures →
EDGAR →
NRSN
Conviction 0HealthcareScan · Mon, Aug 10, 2026NRSN$0.4921-1.56%
ResistanceSupportVol 14Insider buyVol MA14 458.02K
May 11May 28Jun 16Jul 6Jul 23Aug 10
NeuroSense Therapeutics Ltd.www.neurosense-tx.com ↗
Price0.4921
Change-1.56%
Gap+1.02%
Rel volume0.07×
Avg volume338.23K
Avg $ vol172.75K
SMA 200.5861
SMA 500.6813
SMA 2000.8466
Price vs 50-27.77%
Price vs 200-41.87%
MA stackbearish
50/200 cross—
Supertrenddown · 0.6704
RSI (14)31
MACD hist-0.00
MACD cross—
Stoch %K / %D31 / 32
ADX (14)22
+DI / −DI15 / 22
RSI divergence—
MACD divergence—
ATR %+14.19%
ADR %12.52%
52w high1.36
52w low0.4652
From 52w high-63.82%
Above 52w low+5.78%
New 52w highNo
SqueezeOff
Bollinger width64.13%
%B0.25
Donchian pos28.68%
Donchian high0.7385
Donchian low0.3930
AVWAP (52w high)1.06
vs AVWAP high-53.77%
AVWAP (52w low)0.4982
vs AVWAP low-1.22%
OBV trendDown
Chaikin MF (20)-0.15
Today vs 20d0.07×
Avg vol (14d)458.02K
Avg vol (20d)338.23K
Avg $ vol (20d)172.75K
Market cap16.02M
RS 3m (vs SPY)-48.70%
RS 6m (vs SPY)-56.65%
RS line new highNo
Trend template0/8
Technical rank4.4
1 week+5.37%
1 month-32.45%
3 months-44.08%
6 months-47.64%
1 year-62.15%
YTD-36.90%
P/E—
P/B-10.27
P/S—
P/FCF—
EPS—
Div yield—
ROE—
ROA—
Debt/Eq—
Current0.31
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth—
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value15.86M
Revenue—
Net income—
Gross profit—
Free cash flow—
Industry—
ExchangeNasdaq
Shares out32.56M
Employees16
ListedThu, Dec 9, 2021
Free float23.08M
Float %65.3%
Short interest547.54K
Days to cover7.0d
Short volume7.1%
Squeeze score30 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction0 / 100
Pattern quality—
Tech rank4.4 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance0.9249
Support0.4865
Days since event—
Candle confirm—
News sentiment—
Congress activity
Disclosed STOCK Act trades in NRSN
No recent disclosed trades by Congress in NRSN. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in NRSN · 1 buy
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Ben-Noon Alon Chief Executive Officer · Ordinary Shares · 2026-06-16 | Buy | 250K | $200K | 2026-06-16 | 2026-06-17 |
SEC filings
EDGAR filings in NRSN · 9 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.